• About us
• Contact

Advertisement

Organisation › Details

Qiagen N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA)

QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample & Assay Technologies that are used to transform biological materials into valuable molecular information. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies are then used to make these isolated biomolecules visible and ready for interpretation. QIAGEN markets more than 500 products around the world, selling both consumable kits and automation systems to customers through four customer classes: Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharmaceutical and biotechnology companies) and Academia (life sciences research). As of September 30, 2014, QIAGEN employed approximately 4,200 people in over 35 locations worldwide. *

 

	Start	1997-01-01 existent
	Group	Qiagen (Group)
	Predecessor	Diagen
	Industry	sample preparation (technology)
	Industry 2	molecular diagnostics
	Person	Bernard, Thierry (Qiagen 201502– SVP Molecular Dx business area before bioMérieux Corp VP Commcercial Operations)
	Person 2	Sackers, Roland (Qiagen 200408 CFO)
	Street	50 Spoorstraat
	City	5911 KJ Venlo
		Address record changed: 2020-12-02
Basic data	Employees	G: 5,001 to 10,000 (2022-12-31)
	Currency	USD
	Annual sales	2,141,518,000 (net sales, consolidated (2022) 2022-12-31)
	Profit	423,211,000 (2022-12-31)
	Cash	730,669,000 (2022-12-31)
		* Document for »About Section«:
		Record changed: 2024-02-12

Advertisement

More documents for Qiagen (Group)

• [1] Qiagen N.V.. (1/4/24). "Press Release: Qiagen to Accelerate Investments into Qiagen Digital Insights Bioinformatics Business". Venlo....
• [2] Qiagen N.V.. (1/3/24). "Press Release: Qiagen Expands Business in Middle East with New Regional Headquarters and Major Projects". Venlo, Muscat & Ryadh....
• [3] Qiagen N.V.. (9/25/23). "Press Release: Qiagen Enhances QIAwave Portfolio with New Eco-friendlier Nucleic Acid Extraction Kits". Venlo....
• [4] Qiagen N.V.. (9/11/23). "Press Release: Qiagen Launches API to Streamline Access to World-leading Biomedical Data for AI Integration". Venlo & Redwood City, CA....
• [5] Qiagen N.V.. (8/8/23). "Press Release: Qiagen Delivers Ahead of Outlook for Q2 2023 with 9% CER Sales Growth in Non-COVID Products and Updates 2023 Full-year Outlook". Venlo....
• [6] Qiagen N.V.. (8/7/23). "Press Release: Qiagen Receives FDA Approval for Companion Diagnostic to Blueprint Medicines’ Ayvakit (avapritinib) in Gastrointestinal Stromal Tumors". Venlo & Germantown, MD....
• [7] Qiagen N.V.. (7/26/23). "Press Release: Bio-Rad and Qiagen Announce Patent Settlement and Cross-licensing Agreement". Venlo....
• [8] Qiagen N.V.. (6/15/23). "Press Release: Qiagen’s QuantiFERON-TB Gold Plus Shows Unique Clinical Value with CD8 Technology in New Meta-analysis of Tuberculosis Screening". Venlo....
• [9] Qiagen N.V.. (6/13/23). "Press Release: Danish National Genome Center Selects Qiagen for Variant Interpretation in Oncology Genome Sequencing". Venlo & Redwood City, CA....
• [10] Qiagen N.V.. (5/15/23). "Press Release: Qiagen Expands Enzyme Offering to Support Individual Life Science Research Labs Worldwide". Berlin....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.